World Library  
Flag as Inappropriate
Email this Article

Beano (dietary supplement)

Article Id: WHEBN0001972227
Reproduction Date:

Title: Beano (dietary supplement)  
Author: World Heritage Encyclopedia
Language: English
Subject: Antiflatulent, Beano, Block Drug, List of Ig Nobel Prize winners, Dietary supplements
Collection: Antiflatulents, Dietary Supplements, Prestige Brands Brands, Products Introduced in 1990
Publisher: World Heritage Encyclopedia

Beano (dietary supplement)

Beano is an enzyme-based dietary supplement that is used to reduce gas in the digestive tract, thereby improving digestion and reducing bloating, discomfort, and flatulence caused by gas. It contains the enzyme alpha-galactosidase. It was introduced as a liquid, but that has been discontinued and it is now available only as tablets and strawberry-flavored "Meltaways."

Beano is marketed and distributed by Prestige Brands Holdings, Inc.


  • Mechanism of action 1
  • Ingredients 2
  • History 3
  • Use in brewing 4
  • References 5
  • External links 6

Mechanism of action

Beano contains the enzyme alpha-galactosidase, which is derived from the fungus Aspergillus niger. The enzyme works in the digestive tract to break down the complex or branching sugars (polysaccharides and oligosaccharides) in foods such as legumes (beans and peanuts) and cruciferous vegetables (cauliflower, broccoli, cabbage, brussels sprouts, among others). The enzyme breaks those complex sugars into simple sugars, making these foods somewhat more digestible, and reducing intestinal gas.[1]

The polysaccharides and oligosaccharides found in these foods might otherwise pass through the small intestine unaffected. Once in the large intestine, those sugars may be metabolized by intestinal flora, fermenting to produce the gases that cause discomfort.

Two randomized controlled trials show reduction in gas by subjects taking oral alpha-galactosidase.[2][3] Another study indicates alpha-galactosidase may interfere with the diabetic medication acarbose.[4]


Besides the ingredient α-galactosidase, Beano tablets also contain a second enzyme that can be used therapeutically, invertase.[5]


Beano was developed in 1990 by Alan Kligerman of AkPharma after research into gas-causing vegetables that had begun in 1981.[6][7] The idea for such a product was proposed at least as early as the 1780s in Benjamin Franklin's essay "A Letter To A Royal Academy".

Its patent is owned by GlaxoSmithKline which acquired it in 2001 from Block Drug.[8] GlaxoSmithKline sold Beano and 16 other brands to Prestige Brands in 2012.[9]

Beano received a US patent (5445957) on August 29, 1995.[10] The estimated expiration date of this patent is December 5, 2014. As of early 2013 there were more than 4 dozen competing products on the market.

In April 2014, the brand introduced Beano +Dairy Defense [11]

Use in brewing

Simple sugars are also produced as a consequence of the malting process that eventually produces beer. The complex sugars are not broken down by the yeast, and are eventually consumed by the beer drinker, possibly causing flatulence. Homebrewers have found that it is possible to add Beano to their brew to produce a beer that has a less malty flavor.[12] The Beano breaks the complex sugars into simple sugars, and these simple sugars are consumed by the yeast, producing alcohol (or some acetic acid in the aerobic reactions in early fermentation).


  1. ^ Gas in the Digestive Tract - National Digestive Diseases Information Clearinghouse
  2. ^ Di Stefano M, Miceli E, Gotti S, Missanelli A, Mazzoccahi S, Corazza GR (January 2007). "The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms". Dig. Dis. Sci. 52 (1): 78–83.  
  3. ^ Ganiats TG, Norcross WA, Halverson AL, Burford PA, Palinkas LA (November 1994). "Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance". J Fam Pract 39 (5): 441–5.  
  4. ^ Lettieri JT, Dain B (1998). "Effects of beano on the tolerability and pharmacodynamics of acarbose". Clin Ther 20 (3): 497–504.  
  5. ^ B. M. McGrath, G. Walsh 2005. Directory of therapeutic enzymes in Google books
  6. ^ "US Patent 6,344,196". 
  7. ^ "US Patent 5,989,544". 
  8. ^ "GlaxoSmithKline Completes the Purchase of Block Drug for $1.24 Billion".  
  9. ^ Ranii, David (21 December 2011). "GSK sells BC, Goody's and other brands".  
  10. ^ "US Patent 5,445,957". 
  11. ^
  12. ^ "Beano (the anti-gas stuff) helps brewing?".  

External links

  • Beano
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.